Member Info for Vascular

Re: School testing
"To safeguard the health of the teaching workforce and keep as many staff, pupils and students in school and college as possible, we have made rapid lateral flow coronavirus (COVID-19) tests available to schools and colleges. The use of rapid lateral flow tests allows us to identify individuals with coronavirus (COVID-19) who do not have symptoms, which make up around a third of all cases.

Finding asymptomatic cases, along with other infection prevention and control measures such as social distancing, can help us manage the transmission of the virus.

With a phased approach beginning in January, testing has been made available to all schools and colleges."

https://www.gov.uk/government/publications/coronavirus-covid-19-asymptomatic-testing-in-schools-and-colleges/coronavirus-covid-19-asymptomatic-testing-in-schools-and-colleges

Of course any sales abroad is just the icing on the cake

Just to ad that the governments support for the UK fledgling testing and diagnostic industry this past year is not just about covid, its about national security, business continuity and imo the building up of the diagnostic manufacturing industry in the UK by the government is about future security, if and when this happens again. Bearing this in mind they will have to make sure that each manufacturer is provided with the business that they will requite to grow and prosper. I am not so much of a nationalist on personal level but i think that is how it will be handled, and promoted once we can stand on our own feet and manufacture our own products for the UK.

There is going to be a LFT supply switch very shortly in the UK. the past year was a sellers market as far as manufacturing of testing gear was concerned and the UK government, along with many others just had to buy what they could in quantity.
We are now approaching the time where we can as a nation produce our own superior tests, and manufacture them in something like the numbers that will be required, although i still think we may have to fall back on foreign products to fill any gaps.

https://www.nhsggc.org.uk/your-health/health-issues/covid-19-coronavirus/for-nhsggc-staff/lateral-flow-device-testing-guidance/#

https://www.inyourarea.co.uk/news/bromleys-rapid-testing-helps-stop-the-spread-of-covid-19/

Inhaling away the virus: Is the next generation of COVID vaccines on its way?
January 11, 2021

https://www.whmi.com/news/national/inhaling-away-the-virus-is-the-next-generation-of-covid-vacc

looking for a hotel to convert = 100 beds!!

The thing that really puts the pressure on here - whether its a take it to market alone situation for TILS, or a joint venture, or a buy out....... is that this is a COVID -19 and its variants solution is in demand now, 3-5 years down the line is an unknown. Therefore, if TILS or some other Biotech want to squeeze as much revenue from specifically this Covid solution ( i know there are other uses further down the timeline) then they will need to act fast, get this through further trials , regulated and for sale.
Covid will be around for many years to come world wide but the big money form this solution for covid only may be made in a window of only 2-4 years., if the vaccines work.

Well, in situations like that your average PI doesn't stand a chance, wheels within wheels, etc .

Its just the SP reaction here at OO is so unnatural at times .

Take today at 4% spread and the SP has risen ( within spread) 0.2%. = nothing and that's on very good news and on a OK trading day..

This sentence from todays RNS, which is the reason FinnCap published their morning note today.
This from Cathal Executive Chairman
"Our QMB clinic is now close to full capacity until December 2021, and as such, the newly renovated, state of the art Whitechapel Clinic will allow us to increase our study capacity substantially in the year ahead.
We have leased the entire former Whitechapel Hotel and managed to convert the space on a very cost efficient basis which is now almost fully booked to capacity for H1 2021. "

there is a great deal of revenue in those rooms already signed off, plus the likelihood that it will be in demand for the rest of the year. That is future revenue and needs to be included. If i was Cathal , i would send it back and tell them to do it again, and release it with an apology, then dump them.

Its not that they are lazy, it looks to me that todays confirmed revenue growth has been left out on purpose, they must have good reason to deny, and ignore what is not "potential" future revenue, but as confirmed today is real massive growth, much of it booked, confirmed forward sold , call it what you want ....this is real revenue which must now be included in future forecasts....the question is why wouldn't they include this important new revenue, isn't this the reason they revised and published this forecast. This has to be looked at , as investors old and new will be wondering how far will this handicap go, and for how long.

Fantastic news today. I will never understand why this share acts so shy on excellent news! Its not as if this company is off the radar, it has been recommended several times as one of the shares to watch in 2001, so i read here.

Anyway, were at the support of a very good looking channel, with 30p and then 40p clearly in line of direction - just not sure what news will give it that lick up the ar% e to get it moving. lol, there's plenty more news to come our way, i know that. GL

Tiziana Life Sciences hires scientist with track record of successfully developing blockbuster monoclonal antibody products as its chief medical officer.

At Regeneron Pharmaceuticals Inc, Dr Neil Graham was “instrumental” in bringing to market Dupixent and Kevzara
He hailed as a potential “game-changer” the ability to deliver antibody immuno-therapeutics both orally and nasally, an approach being pioneered with Foralumab.
https://www.proactiveinvestors.com/companies/news/938287/tiziana-life-sciences-hires-scientist-with-track-record-of-successfully-developing-blockbuster-monoclonal-antibody-products-as-its-chief-medical-officer-938287.html

If we got FDA fast tracked approval in a few weeks that would be something special.

Brilliant short interview but said so much.... I like the fact he used the word Would wok against all variants, rather than may work. Asked about the time line when their offering could be used against Covid , he stated 6 - 9 months for covid.
Possibly autumn, so not a long wait for the covid solution, with hopefully positive news flow throughout the summer.

What if the FDA fast tracked this one, would that make the process even faster?

Lat minute, it jumped, hit 184 then fell immediately back on selling to £1.60 close.

what?

Why aren't the poles buying over here......? Its looking quite toppy over there, but they just carry on buying relentlessly ...what are they buying on the back of, that we are not privy too. If its news excepted then we have same information and expectations here. there is no way that in this day and age information can be kept secret once out. It must just be on expectations! Anyone.

Lets be honest, people would be less scarred of covid if they new that they could take a inhaler or nasal spray at home once diagnosed, which would protect their lungs from being destroyed by the virus, and meaning that they would not have to go to hospital and provided with oxygen or worse. The Dr here, called these results phenomenal and TILS is the only company in the world who has a a nasal / inhalation delivery of meds, that protects the lungs during a covid attack and and relieves symptoms, and this can be done at the persons home!!

Imagine a day when people can be treated for progressive Covid, at home. Imagine the savings in life and money - especially in places in the world most rural.